Routine

Penicillin allergy de-labelling

De-label · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Most recorded penicillin allergies are inaccurate, leading to inferior, broader-spectrum antibiotic use and worse outcomes. Structured allergy assessment, risk stratification and, where appropriate, direct oral challenge safely remove incorrect labels.

Red flags

  • History of anaphylaxis to a beta-lactam
  • Severe cutaneous adverse reaction (SJS/TEN, DRESS, AGEP)
  • Organ involvement or mucosal blistering with prior reaction
  • Reaction requiring adrenaline/ICU
  • Positive specific IgE/skin test

Assessment

Differential diagnosis

  • True IgE-mediated (type I) anaphylaxis
  • Severe cutaneous adverse reaction (SJS/TEN, DRESS)
  • Non-allergic intolerance (e.g. GI upset)
  • Childhood viral rash mislabelled as allergy
  • Unrelated symptom attributed to the drug

Investigations

  • Detailed allergy history (reaction type, timing, severity, agent)
  • Risk stratification into low vs high risk
  • Specific IgE / skin testing in selected higher-risk cases
  • Review of prior tolerated beta-lactams
  • Documentation of any severe reaction features (blistering, mucosal, organ involvement)
  • Observation setting for challenge if performed

Management

  • Take a structured allergy history focusing on reaction phenotype and timing
  • Identify and permanently avoid high-risk/severe reactions (anaphylaxis, SJS/TEN, DRESS)
  • Risk-stratify remaining patients as low risk suitable for de-labelling
  • For low-risk histories, offer direct oral amoxicillin challenge under observation
  • Use skin testing/specialist referral for intermediate/higher-risk cases
  • Observe after challenge for immediate and delayed reactions
  • Update the allergy record clearly if tolerated
  • Counsel the patient on the corrected status and future antibiotic use
  • Educate that most cephalosporins are safe even with genuine penicillin allergy (low cross-reactivity)
  • Avoid unnecessary second-line antibiotics once de-labelled
  • Provide written confirmation of de-labelling
  • Refer complex cases to allergy/immunology

Drugs & doses

Amoxicillin 250-500 mg PO as a single/graded direct oral challenge dose (low-risk patients)
Observation and resuscitation facilities available during challenge
Appropriate first-line beta-lactam reinstated once de-labelled
Adrenaline/anaphylaxis treatment available as a safety net

Disposition

Outpatient / inpatient allergy or antimicrobial stewardship service; refer severe/complex histories to allergy specialist.

Complications & pitfalls

  • Breakthrough allergic reaction during challenge
  • Re-labelling due to unrelated symptoms
  • Missing a genuine severe allergy if history inadequate
  • Ongoing harm from unaddressed incorrect labels (if not done)
  • Anaphylaxis (rare) during testing

Exam pearls

  • Around 9 in 10 penicillin allergy labels are not true allergy
  • Direct oral challenge is safe and effective for low-risk histories
  • Modern cephalosporins have low cross-reactivity with penicillins
  • Never challenge a history of SJS/TEN, DRESS or anaphylaxis
  • De-labelling improves antimicrobial stewardship and patient outcomes

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.